{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:45:33Z","timestamp":1787312733180,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.medcli.2014.01.032","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T08:48:08Z","timestamp":1395823688000},"page":"497-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype"],"prefix":"10.1016","volume":"142","author":[{"given":"Irene","family":"San Rom\u00e1n-Monserrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Moreno-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"L\u00f3pez-Cuenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rodr\u00edguez-Gonz\u00e1lez-Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Encarna","family":"Guill\u00e9n-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Rodr\u00edguez-Gonz\u00e1lez-Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Alegr\u00eda-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Poza-Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Pi\u00f1ero-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Sornichero-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan R.","family":"Gimeno-Blanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2014.01.032_bib0005","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Anderson-Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.medcli.2014.01.032_bib0010","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac Manifestations of Anderson\u2013Fabry Disease: results from the International Fabry Outcome Survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2014.01.032_bib0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","article-title":"Relationship between X inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the a-galactosidaseA gene in the Czech and Slovak population","volume":"3","author":"Dobrovolny","year":"2005","journal-title":"J Mol Med"},{"issue":"March (5)","key":"10.1016\/j.medcli.2014.01.032_bib0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","article-title":"Fabry disease: identification of 50 novel alphagalactosidase. A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations","author":"Shabbeer","year":"2006","journal-title":"Hum Genomics"},{"issue":"March","key":"10.1016\/j.medcli.2014.01.032_bib0025","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/eurheartj\/ehs166","article-title":"Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis","volume":"34","author":"Yousef","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2014.01.032_bib0030","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.amjcard.2005.05.033","article-title":"Prevalence and Clinical Significance of Cardiac Arrhythmia in Anderson-Fabry Disease","volume":"96","author":"Shah","year":"2005","journal-title":"Am J Cardiol"},{"issue":"May","key":"10.1016\/j.medcli.2014.01.032_bib0035","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"March","key":"10.1016\/j.medcli.2014.01.032_bib0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/hrt.2010.211789","article-title":"Electrocardiographic changes in early recognition of Fabry disease","volume":"97","author":"Namdar","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.medcli.2014.01.032_bib0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","article-title":"Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study","volume":"51","author":"Takenaka","year":"2008","journal-title":"J Cardiol"},{"key":"10.1016\/j.medcli.2014.01.032_bib0050","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1540-8159.2008.01088.x","article-title":"Short PR interval in the absence of preexcitation: a characteristic finding in a patient with Fabry disease","volume":"31","author":"Aryana","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"issue":"January (4)","key":"10.1016\/j.medcli.2014.01.032_bib0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N Engl J Med"},{"issue":"September (7)","key":"10.1016\/j.medcli.2014.01.032_bib0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.medcli.2009.11.044","article-title":"Role of cardiac magnetic resonance in cardiac involvement of Fabry disease","volume":"135","author":"Serra","year":"2010","journal-title":"Med Clin (Barc)"},{"issue":"June (6)","key":"10.1016\/j.medcli.2014.01.032_bib0065","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/ndt\/gfp105","article-title":"Nephropathy in Fabry disease: the importance of early diagnosis and testing in high risk populations","author":"Oqvist","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.medcli.2014.01.032_bib0070","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.amjhyper.2006.01.011","article-title":"Prevalence of uncontrolled hypertension in patients with Fabry disease","volume":"19","author":"Kleinert","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.medcli.2014.01.032_bib0075","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1523-1755.2004.00846.x","article-title":"Parapelvic kidney cysts: a distinguishing feature with high prevalence in Fabry disease","volume":"66","author":"Ries","year":"2004","journal-title":"Kidney Int"},{"issue":"July (4)","key":"10.1016\/j.medcli.2014.01.032_bib0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.medcli.2011.02.024","article-title":"Consensus for the study and treatment of Fabry disease. GETER Foundation","volume":"137","author":"Garc\u00eda de Lorenzo","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2014.01.032_bib0085","first-page":"2609","article-title":"Antiproteinuric therapy and Fabry nephropathy: sustained reduction in proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta","volume":"18","author":"Tahir","year":"2007","journal-title":"J Am SocNephrol"},{"key":"10.1016\/j.medcli.2014.01.032_bib0090","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/TP.0b013e318191a842","article-title":"Kidney transplant outcomes in patients with Fabry disease","volume":"87","author":"Shah","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.medcli.2014.01.032_bib0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2014.01.032_bib0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"65","author":"Whybra","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.medcli.2014.01.032_bib0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.medcli.2014.01.032_bib0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bjo.2006.100602","article-title":"Ocular manifestations of Fabry disease: data from the Fabry outcome survey","volume":"91","author":"Sodi","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.medcli.2014.01.032_bib0115","first-page":"713","article-title":"Ophtalmological manifestations of Fabry's disease. About 4 cases with deficient activity of Alpha Galactosidase A","volume":"83","author":"Rodr\u00edguez Gonz\u00e1lez-Herrero","year":"2008","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.medcli.2014.01.032_bib0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.survophthal.2008.04.005","article-title":"Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder","volume":"53","author":"Samiy","year":"2008","journal-title":"Surv Ophtalmol"},{"key":"10.1016\/j.medcli.2014.01.032_bib0125","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study","volume":"366","author":"Rolfs","year":"2005","journal-title":"Lancet"},{"issue":"October (13)","key":"10.1016\/j.medcli.2014.01.032_bib0130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1157\/13093265","article-title":"Fabry disease in Spain: first analysis of the response to enzyme replacement therapy","volume":"127","author":"Rivera Gallego","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2014.01.032_bib0135","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00415-007-0575-y","article-title":"Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy","volume":"254","author":"Palla","year":"2007","journal-title":"J Neurol"},{"issue":"June (2)","key":"10.1016\/j.medcli.2014.01.032_bib0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1157\/13063178","article-title":"Fabry's disease in Spain. Study of 24 cases","volume":"123","author":"Barba Romero","year":"2004","journal-title":"Med Clin (Barc)"},{"issue":"October (9)","key":"10.1016\/j.medcli.2014.01.032_bib0145","first-page":"379","article-title":"Comparison of patients from a Spanish Registry of Fabry disease in two periods","volume":"139","author":"Barba Romero M\u00c1","year":"2012","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2014.01.032_bib0150","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/jmedgenet-2011-100407","article-title":"Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease","volume":"49","author":"Hughes","year":"2012","journal-title":"J Med Genet"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531400133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577531400133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T13:22:00Z","timestamp":1538745720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577531400133X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S002577531400133X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2014.01.032","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2014.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}